Sun Pharma Inks Agreement With US-Based Pharmazz on Cerebral Ischemic Stroke Drug September 15, 2023 The Indian multinational pharmaceutical company, Sun Pharmaceutical has entered into a licence agreement with US-based Pharmazz Inc. to commercialise Tyvalzi (Sovateltide), in India.
Page 1 of 1